SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros results sharply exceeded expectations and its raised outlook, fueled by AI-server demand, are driving attention. Many traders see the shares as undervalued and anticipate short covering, while others point to thin margins, negative operating cash flow, and lingering doubts about management credibility to explain the muted reaction.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs better-than-expected quarterly results and stronger outlook, driven by surging AI and data-center demand, are fueling a sharp rally and optimism about continued growth. Some traders remain wary of valuation, weaker cash flow and margin concerns, and the companys growing reliance on data-center spending, with debate over whether the gains will hold.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Attention centers on the U.S. midterm elections and shifting expectations for control of Congress, with traders debating whether a Democratic wave and a weakened Trump administration could weigh on DJT or whether Republican gains would support the stock. The discussion is highly polarized, and election outcomes and their market impact remain uncertain.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas is drawing attention after beating quarterly revenue and adjusted-EPS expectations and giving stronger next-quarter revenue guidance, while its AI-data-center power business remains a key part of the growth story. Bulls see renewed growth and NVIDIA-related 800V power work as validation; skeptics say revenue is still small and the collaboration has not yet produced clearly disclosed customer orders or profitability.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Aristas stronger-than-expected quarterly results and upbeat next-quarter outlook, supported by AI networking demand, are driving attention and a sharp earnings-related rally. Traders are largely celebrating the beat and guidance, while some caution that elevated valuation and profit-taking could make the move volatile.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs strong quarterly results and raised outlook have drawn attention, but shares fell despite the beat, prompting frustration among bulls and renewed concern about its premium valuation and a possible sell-the-news reaction. Traders remain divided on whether rapid AI-connectivity growth justifies the price or whether doubts about AI infrastructure spending and limited near-term buying will keep pressure on the stock.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on a letter from 28 HOPE-3 investigators urging FDA approval of deramiocel for non-ambulatory Duchenne muscular dystrophy, ahead of the agencys Nov. 22 decision. Many traders view the letter as strengthening the case and cite short-covering as a possible contributor to the rally, while others remain cautious about the FDAs prior statistical concerns and the binary decision risk.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters quarterly results and raised revenue outlook are driving attention, with traders highlighting strong growth, higher sensor shipments and narrowing losses. The reaction is broadly optimistic, though some remain cautious about weaker gross margins, continued losses and volatile price action.

Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the following segments: Square and Cash App. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA.

Block Inc - Ordinary Shares - Class A

Block Inc

Blocks Q3 results and higher full-year profit outlook are driving attention, with bullish traders pointing to growth across Cash App and Square. Skeptics question the quality of the beat, citing a Bitcoin revaluation gain, rising credit losses and expenses, while the share-price response has frustrated both camps.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyxs Q3 update has traders focused on deeper cost cuts and the companys 2027 profitability goal, while discussion of setrusumab centers on whether existing osteogenesis imperfecta data can support a path forward with the FDAa question the company has not resolved. Reactions are mixed: some view spending discipline and filing-related work as encouraging, while others point to the earnings miss and UX701 setback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stonk Trades

Indy

BioTechBul

Charles ford

MacUlkinMarvSpider615

$ABCL $MRNA $REGN $SLS $JNJ 

Now everyone is finding themselves chasing…

All those sellers are now buying it up. 

Earnings coming up in a few days …November 9th 

Follow by 2 huge biotech conferences that they will be presenting at. 

November 9: Q3 earnings and pipeline update.
November 11: Stifel Healthcare Conference.
November 16: Jefferies Global Healthcare Conference in London.

👀